Former cancer patients not more likely to die from COVID
A study finds that former cancer patients are not more likely to die from COVID than non-cancer patients, if they aren't having active treatment.
Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer
Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.
“Inadequate” UK cancer services risk late diagnosis for patients
According to a report, more than 340,000 cancer patients could face late diagnosis - due to NHS staff shortages.
Cytomegalovirus & glioblastoma: Solving the riddle
Sean Lawler, Associate Professor at Brown University, explains solving the riddle when it comes to the cytomegalovirus virus and the lethal brain tumour, glioblastoma.
Visualising genomic instability in cancer
Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.
Cholangiocarcinoma research and asbestos exposure
Professor Giovanni Brandi and Dr Simona Tavolari, explore the link between asbestos exposure and cholangiocarcinoma malignancies
Therapeutic feline and canine cancer vaccine
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
A new wave of molecular cancer therapeutics
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Drug with the ability to reprogramme aggressive brain tumours
Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour
Ultrasounds to detect prostate cancer are highly successful
An ultrasound can diagnose most prostate cancer cases in men with great accuracy – only missing 3.4% of severe cases.
Optimising AI tools for mammography clinical practice
Lester Litchfield, Data & Science Manager, Volpara Health, explores how to build confidence in the use of AI for mammography clinical practice
Artificial Intelligence (AI)...
Examining intersectionality to find disparities in cancer care
Analysis of 28 studies has found that the intersection of sexual minority status with ethnicity is associated with lower cancer screenings.
Lower cancer risk in diets with lower meat intake
Researchers analysing dietary habits find that those who consume meat five times or less weekly have a lower cancer risk.
New potential therapy for aggressive bladder cancer
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Single cell cancer research
Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.
Non-melanoma skin cancer
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.
Scientists discover new treatment to fight pancreatic cancer
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
Scientists use tumour-fighting cells to treat breast cancer
An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.
